Get the Stockscreener App
0.582
3.88%
-0.0235
Pre-market:
.58
-0.002
-0.34%
Mdxhealth Sa stock is traded at $0.582, with a volume of 222.59K.
It is down -3.88% in the last 24 hours and down -21.49% over the past month.
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.
See More
Previous Close:
$0.6055
Open:
$0.6046
24h Volume:
222.59K
Relative Volume:
0.04
Market Cap:
$55.53M
Revenue:
$110.97M
Net Income/Loss:
$-33.18M
P/E Ratio:
-0.8853
EPS:
-0.6574
Net Cash Flow:
$-11.80M
1W Performance:
-13.35%
1M Performance:
-21.49%
6M Performance:
-79.93%
1Y Performance:
-86.71%
1-Day Range:
$0.5628
$0.6046
1-Week Range:
$0.5628
$0.6815
52-Week Range:
$0.40
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Compare MDXH vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
0.582 | 55.53M | 110.97M | -33.18M | -11.80M | -0.6574 |
TMO
Thermo Fisher Scientific Inc
|
678.39 | 250.83B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
223.77 | 157.31B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
408.79 | 58.92B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.84 | 48.73B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
275.02 | 45.27B | 16.63B | 1.39B | 2.12B | 8.0674 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | Craig Hallum | Buy |
| Oct-31-24 | Initiated | Lake Street | Buy |
| May-31-23 | Initiated | TD Cowen | Outperform |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
Mdxhealth Sa Stock (MDXH) Latest News
MDxHealth stock holds steady as investors digest latest quarterly figures - AD HOC NEWS
A 10% owner of MDxHealth (NASDAQ: MDXH) plans a stock sale - Stock Titan
MDXH Price Today: MDxHealth SA Stock Price, Quote & Chart | MEXC - MEXC
MDxHealth Files 2026 Interim Report as Losses Deepen but Fresh Capital Extends Runway - TipRanks
MDxHealth (MDXH) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Execution - Yahoo Finance
MDxHealth SAADR Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
MDxHealth (Nasdaq: MDXH) faces going-concern doubts after interim loss - Stock Titan
MDxHealth (MDXH) Holds Steady Near $0.72 as Consolidation Persists Between Key LevelsLarge Cap Trends - dars.gov.et
MDxHealth stock extends strong August rally after beating Q2 revenue expectations - AD HOC NEWS
MDxHealth (MDXH) Range: Finishes 1.39% Down at $0.73 in the Latest Reading; Range View: Support at $0.69 and Resistance at $0.77 Frame the RangeChannel Breakout - careplusvn.com
MDxHealth (MDXH) Momentum: Finishes 3.19% Up at $0.74 for the Current Session; Chart Watch - vinanet.vn
MDXH Maintained by BTIG -- Price Target Lowered to $2.00 - GuruFocus
MDxHealth price target lowered to $2 from $4 at BTIG - TipRanks
BTIG cuts MDxHealth stock price target on higher share count - Investing.com
MDxHealth revenue up 16% in Q2, stock surges on guidance affirmation - scanx.trade
MDxHealth (MDXH) Q2 2026 Earnings Call Transcript - The Globe and Mail
MDxHealth (MDXH) Chart: Records a 5.15% Decrease to $0.72; Key Range: the Current Price Sits Inside the Supplied Technical Range on the DayRegression Channel - vinanet.vn
MDxHealth (MDXH) Earnings Reading: Reported EPS Tops Expectations for the Current Session; Share Move - vinanet.vn
MDxHealth (MDXH) Earnings Update: EPS Prints Above Forecast in Latest Trading; Post-Report: The Stock Ends Down 12.20% in the Available RecordTech Earnings Analysis - dars.gov.et
MDxHealth (MDXH) investors reveal 19.5% and 12.1% stakes - Stock Titan
MDxHealth (MDXH) Surges 4.58% to $0.84, Approaching Key Resistance at $0.88Cumulative Volume - vinanet.vn
MDxHealth (MDXH) Surges 74.89% to $0.81 as Momentum Builds in Diagnostic OncologyTime Weighted Price - vinanet.vn
MDxHealth (MDXH) Skyrockets 74.9% to $0.81: Key Levels to Watch After Explosive MoveLast Point Resistance - vinanet.vn
MDxHealth price target lowered to $3 from $5 at Lake Street - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
MDxHealth Says Well-Positioned to 'Return to Positive EBITDA' - Sahm
MDxHealth (MDXH) Q2 2026 Earnings Call: Umsatz erholt sich, Prognose bestätigt - TradingKey
Mdxhealth S.A. Earnings Call Shows Growth, Strain - TipRanks
MDXH Maintained by Lake Street -- Price Target Lowered to $3.00 - GuruFocus
Bleichroeder LP Discloses Investment at MDxHealth SA with 33.2% Stake - TradingView
MDxHealth SA Stock 12‑Month Price Target Cut to $2.2, Implies 376% Upside - TradingView
Bleichroeder (MDXH) reports 31.6M-share, 33.2% holding in MDxHealth - Stock Titan
MDxHealth SA Stock 12‑Month Price Target Cut to $2.6, Implies 463% Upside - TradingView
MDxHealth S.A. Q2 2026 Earnings Call Summary - Yahoo Finance
Conferencia de resultados del T2 de 2026 de MDxHealth (MDXH): los ingresos se recuperan, se mantienen las previsiones - TradingKey
MDxHealth (MDXH) Q2 2026 Earnings Call: Revenue Rebounds, Guidance Maintained - TradingKey
Mdxhealth Reports Second Quarter 2026 Financial Results - The Manila Times
MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record S - GuruFocus
MDxHealth SA (MDXH) (Q2 2026) Earnings Call Highlights: Record Sequential Growth and Strategic ... - finance.yahoo.com
Earnings call transcript: MDxHealth tops revenue estimates in Q2 2026 By Investing.com - Investing.com Canada
MDXH Looks 79.0% Undervalued on GF Value™ but Faces Value Trap W - GuruFocus
Earnings call transcript: MDxHealth tops revenue estimates in Q2 2026 - Investing.com
MDxHealth SA (MDXH) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Full Transcript: MDxHealth Q2 2026 Earnings Call - Benzinga
MDxHealth SA reports results for the quarter ended June 30Earnings Summary - TradingView
MDxHealth Raises $20 Million in Direct Share Offering and Amends Articles After Capital Increase - TipRanks
MDxHealth Posts Q2 2026 Revenue Growth, Exits Resolve Business and Raises $20 Million - TipRanks
MDxHealth ADR earnings missed, revenue topped estimates - Investing.com
MDXHEALTH SA ($MDXH) Releases Q2 2026 Earnings - Quiver Quantitative
MDxHealth (MDXH) sells 44M shares, lifting total stock to 95.4M - Stock Titan
MDxHealth (NASDAQ: MDXH) lifts Q2 2026 revenue 16% but posts deeper loss - Stock Titan
Mdxhealth Sa Stock (MDXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):